Loading…

Immune Evasion of SARS-CoV-2 Omicron Subvariants

Since the SARS-CoV-2 Omicron variant (B.1.1.529) was declared a variant of concern (VOC) by the WHO on 24 November 2021, it has caused another global surge of cases. With extensive mutations in its spike glycoprotein, Omicron gained substantial capabilities to evade the antiviral immunity provided b...

Full description

Bibliographic Details
Main Authors: Ke, Hanzhong, Chang, Matthew R., Marasco, Wayne A.
Format: Online Article Text
Language:English
Published: MDPI 2022
Subjects:
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501521/
https://www.ncbi.nlm.nih.gov/pubmed/36146623
http://dx.doi.org/10.3390/vaccines10091545